Search Here

A pioneering surgery that introduced a successful non-surgical technique in removing malignant cancer tumors in the breast has been successfully performed in Southend Hospital, Essex. The surgery was successfully done by the consultant radiologist of the hospital, Dr. Taghreed Toma and under general anesthesia.

Reports from Mirror UK revealed that Dr. Toma was already carrying out the treatment since 2005 and has been performing vacuum-assisted excision at the Southend Hospital for benign lesions. Despite his patient having additional conditions, his team felt that the procedure was ideal for the particular case.

The procedure required ultrasound and mammogram images during the actual procedure to be able to see if all the lumps being extracted are completely removed. The successful operation had a patient with 5mm cancer and was not induced with any form of anesthetic. The patient procedure took around half an hour and patients can immediately go home afterward.

The most significant benefit of the operation is that a needle puncture to the skin was all it took to remove the benign cancer cells. Patients can also continue with their normal activities afterward, something impossible in surgical procedures.

Meanwhile, Telegraph UK reveals that in recent findings, women who were diagnosed with DCIS, a form of non-invasive cancer, who underwent breast cancer screening are more health-conscious compared to the general population of women. Diagnosis of DCIS also does not increase the risk of a patient dying.

However, although DCIS is a non-invasive form of breast cancer, it can still progress into an invasive form of breast cancer that is life-threatening and can only be treated by surgery and radiation.

The pioneered study, however, opens several possibilities in creating more ways in treating and preventing breast cancer cells from spreading. Research also reveals that early screening and detection will eventually lead to a saved life needless of the treatment that they will undergo to remove breast cancer cells.